Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Parenting Pain Away: Development and usability testing of an educational website about infant procedural pain management.

Paediatric & neonatal pain·2024

Same author

Help-seeking intentions of UK construction workers: a cross-sectional study.

Occupational medicine (Oxford, England)·2024

Same author

Cursor movements to targets labelled "stop": a kinematic analysis.

Ergonomics·2022

Same author

Low-dose Perioperative Dexamethasone Improves 24-hour Post-Operative Pain after Anterior Cruciate Ligament Reconstruction.

Malaysian orthopaedic journal·2022

Same author

Emergence of Multidrug- and Pandrug- Resistant <i>Pseudomonas aeruginosa</i> from Five Hospitals in Qatar.

Infection prevention in practice·2021

Same author

Extended anharmonic collapse of phonon dispersions in SnS and SnSe.

Nature communications·2020

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Evolution of interventions for complex coronary lesions.

R Sachdeva¹, S Prayaga, D Bansal

¹Department of Internal Medicine, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System Little Rock, AR, USA. RSachdeva@uams.edu

Minerva Cardioangiologica

|February 10, 2009

Summary

This summary is machine-generated.

Percutaneous coronary intervention (PCI) is increasingly used in complex patients due to improved technology and techniques. This review covers strategies for managing challenging coronary lesions and high-risk individuals undergoing PCI.

Related Experiment Videos

Last Updated: Jun 25, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Area of Science:

Interventional Cardiology
Cardiovascular Medicine
Medical Technology

Background:

Percutaneous coronary intervention (PCI) use has grown significantly.
Indications have expanded to include patients with complex conditions like extensive coronary disease, multiple risk factors, older age, and comorbidities.
Advances in PCI equipment, techniques, and support systems have enabled treatment for previously high-risk patients.

Purpose of the Study:

To review the challenges associated with complex coronary lesions.
To discuss interventional and pharmacologic strategies for optimizing PCI outcomes.
To highlight novel technologies in the field of percutaneous coronary intervention.

Main Methods:

Literature review of recent advancements in PCI.
Analysis of strategies for managing complex coronary lesions.
Evaluation of interventional and pharmacologic approaches.
Discussion of emerging technologies and support systems.

Main Results:

PCI is now feasible and safe for a broader range of complex patients.
Technological and technical improvements have expanded PCI indications.
Various strategies exist to manage complex lesions and high-risk patients effectively.
Novel technologies are continuously emerging to enhance PCI outcomes.

Conclusions:

The expansion of PCI indications is supported by technological and procedural advancements.
Effective management of complex coronary lesions and high-risk patients requires a multifaceted approach.
Ongoing innovation in PCI technology promises further improvements in patient care and outcomes.